A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

During his tenure, Mr. Lubin grew Ledger Run into a leading technology company in the clinical trial operations market. Driven by Mr. Lubin's vision and leadership, Ledger Run has developed into a ...

INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable ...

SCOPE Conference (Summit for Clinical Ops Executives), held last week in Orlando, FL, brought together more than 4,500 industry ...

Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just ...

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...